Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125450391 | 12545039 | 1 | I | 20020328 | 20121210 | 20160711 | 20160711 | EXP | CA-PFIZER INC-1528104 | PFIZER | 60.00 | YR | F | Y | 0.00000 | 20160711 | OT | GB | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125450391 | 12545039 | 1 | PS | DOCETAXEL. | DOCETAXEL | 1 | 134 MG, EVERY 3 WEEKS | 536 | MG | Y | 22234 | 134 | MG | SOLUTION FOR INJECTION | Q3W | ||||
| 125450391 | 12545039 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | 564 MG, EVERY 3 WEEKS | 1113 | MG | 76517 | 564 | MG | SOLUTION FOR INJECTION | Q3W | |||||
| 125450391 | 12545039 | 3 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | 549 MG, EVERY 3 WEEKS | 1113 | MG | 76517 | 549 | MG | SOLUTION FOR INJECTION | Q3W | |||||
| 125450391 | 12545039 | 4 | SS | CISPLATIN. | CISPLATIN | 1 | 75 MG/M2, EVERY 3 WEEKS | 150 | MG/M2 | U | 0 | 75 | MG/M**2 | SOLUTION FOR INJECTION | Q3W | ||||
| 125450391 | 12545039 | 5 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 292 MG, ONCE | Y | 0 | 292 | MG | |||||||
| 125450391 | 12545039 | 6 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 146 MG, WEEKLY | Y | 0 | 146 | MG | /wk | ||||||
| 125450391 | 12545039 | 7 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | UNK | Y | 0 | ||||||||||
| 125450391 | 12545039 | 8 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | 146 MG, UNK | Y | 0 | 146 | MG | ||||||||
| 125450391 | 12545039 | 9 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | UNK | Y | 0 | ||||||||||
| 125450391 | 12545039 | 10 | C | BENALAPRIL | ENALAPRIL MALEATE | 1 | UNK | 0 | |||||||||||
| 125450391 | 12545039 | 11 | C | ZOCOR | SIMVASTATIN | 1 | NOT REPORTED,NOT REPORTED | 0 | |||||||||||
| 125450391 | 12545039 | 12 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125450391 | 12545039 | 13 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | NOT REPORTED,NOT REPORTED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125450391 | 12545039 | 1 | Breast cancer |
| 125450391 | 12545039 | 2 | Breast cancer |
| 125450391 | 12545039 | 4 | Breast cancer |
| 125450391 | 12545039 | 5 | Breast cancer |
| 125450391 | 12545039 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125450391 | 12545039 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125450391 | 12545039 | Febrile neutropenia | |
| 125450391 | 12545039 | Nervous system disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125450391 | 12545039 | 1 | 20011228 | 20020320 | 0 | |
| 125450391 | 12545039 | 2 | 20020320 | 20020320 | 0 | |
| 125450391 | 12545039 | 3 | 20020227 | 20020227 | 0 | |
| 125450391 | 12545039 | 4 | 20011228 | 20020206 | 0 | |
| 125450391 | 12545039 | 5 | 20011227 | 20011227 | 0 | |
| 125450391 | 12545039 | 6 | 200201 | 0 | ||
| 125450391 | 12545039 | 7 | 20020320 | 0 | ||
| 125450391 | 12545039 | 8 | 20020327 | 0 | ||
| 125450391 | 12545039 | 9 | 20020403 | 0 |